Category
Metabolic & Energy Peptides
Regulation and homeostasis
Showing 4 products
Metabolic & Energy
MOTS-C
MOTS-C (Mitochondrial Open reading frame of the twelve S rRNA-c, CAS# 1627580-64-6) is a 16-amino-acid mitochondria-derived peptide (MDP) encoded within the 12S rRNA gene of mitochondrial DNA — making it one of a small class of bioactive peptides with a mitochondrial rather than nuclear genomic origin. MOTS-C is studied in preclinical research for its role in mitochondria-to-nucleus retrograde signalling and its involvement in AMPK pathway activation, the folate cycle, de novo purine synthesis, and metabolic regulation models. Under cellular stress conditions, MOTS-C has been shown to translocate from mitochondria to the nucleus in vitro, where it interacts with nuclear gene regulatory elements. Supplied by BIOSTACKS as a lyophilized powder for in vitro laboratory research use. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.
Skin & Hair
GLOW
Glow Blend is a triple-peptide research formulation combining GHK-Cu (Copper Tripeptide-1), BPC-157 (Body Protection Compound-157), and TB-500 (Thymosin Beta-4) in a single lyophilized vial. Each component engages distinct molecular targets — Cu²⁺-mediated gene expression and ECM pathway research (GHK-Cu), FAK-paxillin and VEGF signalling models (BPC-157), and G-actin sequestration and ILK pathway studies (TB-500) — making this blend a multi-target tool formulation for laboratory models investigating cellular signalling, matrix biology, and cytoskeletal dynamics. Supplied by BIOSTACKS as a lyophilized powder for in vitro laboratory research use. This product has not been authorized by Health Canada for any therapeutic, clinical, or human use.
Recovery
Pulse (CJC + Ipamorelin)
CJC-1295 No DAC (Mod GRF(1-29), CAS# 863288-34-0) is a synthetic 29-amino acid analogue of growth hormone-releasing hormone (GHRH) with binding activity at the GHRH receptor (GHRHR). Unlike the DAC-modified variant, this form lacks the Drug Affinity Complex modification, resulting in a distinct pharmacokinetic profile relevant to short-duration signalling studies. Supplied by BIOSTACKS as a lyophilized powder for in vitro laboratory research use. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.
Longevity
SS-31
SS-31 (Elamipretide; MTP-131) is a synthetic cell-permeable tetrapeptide developed by Hazel Szeto and Peter Schiller, featuring an alternating aromatic–cationic residue pattern — D-Arg-Dmt-Lys-Phe-NH₂ — where Dmt denotes 2′,6′-dimethyltyrosine. This motif enables selective accumulation at the inner mitochondrial membrane through electrostatic and hydrophobic interactions with cardiolipin (CL), an anionic phospholipid essential to electron transport chain organisation. SS-31 is a widely used tool compound in mitochondrial biology research for investigating cristae architecture, respiratory complex dynamics, and reactive oxygen species production.